Where does Boehringer Ingelheim International GmbH rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Boehringer Ingelheim International GmbH ranks #678 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Boehringer Ingelheim International GmbH hold?

Boehringer Ingelheim International GmbH holds 662 US utility patents granted between 2015 and 2025, spanning 61 technology areas.

What is Boehringer Ingelheim International GmbH's Innovation Score?

Boehringer Ingelheim International GmbH has an Innovation Score of 63.6 out of 100 (top 2% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Boehringer Ingelheim International GmbH focus on?

Boehringer Ingelheim International GmbH's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 468 patents, ranking #22 of 6,058 assignees active in that subclass. Grants appear in 61 CPC subclasses total.

Is Boehringer Ingelheim International GmbH's patent grant rate increasing or decreasing?

Boehringer Ingelheim International GmbH's recent grant velocity is -44% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Boehringer Ingelheim International GmbH's patents?

Boehringer Ingelheim International GmbH's patents average 17.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Boehringer Ingelheim International GmbH

Q: How is the Boehringer Ingelheim International GmbH patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 662 granted patents across 61 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Boehringer ranks #678 of 49,997 tracked US assignees by granted-patent volume, with 662 patents across 61 technology areas.

#678
of 49,997 US assignees by volume: Top 2%
by Innovation Score (63.6/100): 17.1
avg claims per patent: -44%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R678 · Foreign Corporation #678 · 662 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MID 662 grants
TOP-DECILE #678/49,997
PHOTO-FINISH Datang Mobile…
CPC-WIDE A61P · 61 areas
INNOV-STRONG 63.6/100
CLAIMS-RICH 17.1 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -44% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Datang Mobile Communications Equipment Co., Ltd. (±1 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Boehringer’s 63.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 22.4 pts (35%) Velocity 5.9 pts (9%) Breadth 25.0 pts (39%) Claim depth 10.3 pts (16%)

Qualcomm Incorporated · highest

85
Assa Abloy AB · near

64
Boehringer Ingelheim… · this assignee

64
Kimberly-Clark… · near

64
Maxell · near

64
Yeda Research AND… · near

64
3D Lighting… · lowest

7

What this shows Boehringer's Innovation Score is 63.6/100 (top 2% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Boehringer?

Each dot is one of Boehringer’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Boehringer’s own 17.1 claims/patent is ABOVE the 15.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Boehringer vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

How Boehringer's grant cadence moved

Between 2020–2024, Boehringer Ingelheim International GmbH received 224 grants versus 402 in 2015–2019 (-44% equal-window velocity, below median growth). Across complete PatentsView years, output peaked in 2015 at 148 grants and bottomed in 2022 at 35. Lead class A61P accounts for 70.7% of the portfolio across 61 subclasses. Volume neighbours: Socionext Inc. (#674) and Pfizer Inc. (#682).

Boehringer's three-year grant acceleration

From 2019–2021 to 2022–2024, Boehringer Ingelheim International GmbH moved from 148 to 131 grants (0.89x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,532. See the growth leaderboard.

Socionext

668
Takeda Pharmaceut…

668
thyssenkrupp

665
Groupon

664
Boehringer Ingelh… ◀

662
Datang Mobile Com…

661
Ordos Yuansheng O…

661
Accenture Global…

660
Pfizer

659

What this shows Boehringer holds 662 patents at rank #678, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Boehringer

By rank, the assignees closest to #678 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Boehringer's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Boehringer, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Boehringer ranks #22 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (64 here).

Maxell, Ltd. 64 Kimberly-Clark Worldwide, Inc. 64 Assa Abloy AB 64 Yeda Research AND Development Co. Ltd. 64

Similar claim depth

Nearest assignees by average claims per patent (17.1 here).

Bell Helicopter Textron Inc. 17.1 avg Mitsubishi Electric Research Laboratories, Inc. 17.1 avg Nordson Corporation 17.1 avg DePuy Synthes Products, Inc. 17.1 avg

Boehringer's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

64 Top 2% higher than 98% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Boehringer Ingelheim International GmbH patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	148	22.4%
2016	85	12.8%
2017	53	8.0%
2018	61	9.2%
2019	55	8.3%
2020	48	7.3%
2021	45	6.8%
2022	35	5.3%
2023	41	6.2%
2024	55	8.3%
2025partial year	36	5.4%

Which technologies does Boehringer Ingelheim International GmbH patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 468

C07D - Heterocyclic Compounds 359

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 324

C07K - Peptides 101

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 73

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 48

B05B - Spraying APPARATUS; Atomising APPARATUS; Nozzles 42

C07C - Acyclic OR Carbocyclic Compounds 32

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 25

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 23

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 21

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 19

Y02A - Technologies FOR Adaptation TO Climate Change 19

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 16

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 12

Top 15 of 61 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Boehringer Ingelheim International GmbH's patent record in context - here's where to go next.

Boehringer Ingelheim International GmbH's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 70.7% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #678 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Boehringer Ingelheim International GmbH against Socionext Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 63.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.